Prophylactic role of curcumin in dextran sulfate sodium (DSS)-induced ulcerative colitis murine model

Food and Chemical Toxicology

Volumn 47, Issue 6, 2009, Pages 1311-1317

  Arafa, Hossam M M ^a   Hemeida, Ramadan A ^a   El Bahrawy, Ali I M ^a   Hamada, Farid M A ^a  

^a Al Azhar University   (Egypt)

Author keywords

Anti oxidant; Curcumin; Dextran sulfate sodium (DSS); MPO; NO; TNF ; Ulcerative colitis

Indexed keywords

CURCUMIN; DEXTRAN SULFATE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; MALONALDEHYDE; MYELOPEROXIDASE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ABSCESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CELL INFILTRATION; COLON; CONTROLLED STUDY; ENZYME ACTIVITY; HEMATOCHEZIA; LIPID PEROXIDATION; MALE; NONHUMAN; ORGAN WEIGHT; PROTEIN BLOOD LEVEL; RAT; SINGLE DRUG DOSE; ULCER; ULCERATIVE COLITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLITIS, ULCERATIVE; COLON; CURCUMIN; DEXTRAN SULFATE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; INTESTINAL MUCOSA; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MICE; NITRIC OXIDE; PEROXIDASE; RATS; TUMOR NECROSIS FACTOR-ALPHA;

CURCUMA LONGA; MURINAE; RATTUS;

EID: 67349227422     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2009.03.003     Document Type: Article

References (52)

1. Arafa H.M. Curcumin attenuates diet-induced hypercholesterolemia in rats. Med. Sci. Monit. 11 (2005) BR228-BR234
2. Barbosa D.S., Cecchini R., El Kadri M.Z., Rodríguez M.A., Burini R.C., and Dichi I. Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty acids. Nutrition 19 (2003) 837-842
3. Bayrak O., Uz E., Bayrak R., Turgu F., Atmaca A.F., Sahin S., Yildirim M.E., Kaya A., Cimentepe E., and Akcay A. Curcumin protects against ischemia/reperfusion injury in rat kidneys. World J. Urol. 26 (2008) 285-291
4. Berkhout M., Friederich P., van Krieken J.H., Peters W.H., and Nagengast F.M. Low detoxification capacity in the ileal pouch mucosa of patients with ulcerative colitis. Inflamm. Bowel Dis. 12 (2006) 112-116
5. Camacho-Barquero L., Villegas I., Sánchez-Calvo J.M., Talero E., Sánchez-Fidalgo S., Motilva V., and Alarcón de la Lastra C. Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. Int. Immunopharmacol. 7 (2007) 333-342
6. Chen H.W., Kuo H.T., Chai C.Y., Ou J.L., and Yang R.C. Pretreatment of curcumin attenuates coagulopathy and renal injury in LPS-induced endotoxemia. J. Endotoxin Res. 13 (2007) 15-23
7. Chung H.L., Yue G.G., To K.F., Su Y.L., Huang Y., and Ko W.H. Effect of Scutellariae radix extract on experimental dextran-sulfate sodium-induced colitis in rats. World J. Gastroenterol. 13 (2007) 5605-5611
8. Cross R.K., and Wilson K.T. Nitric oxide in inflammatory bowel disease. Inflamm. Bowel Dis. 9 (2003) 179-189
9. Damiani C.R., Benetton C.A., Stoffel C., Bardini K.C., Cardoso V.H., Di Giunta G., Pinho R.A., Dal-Pizzol F., and Streck E.L. Oxidative stress and metabolism in animal model of colitis induced by dextran sulfate sodium. J. Gastroenterol. Hepatol. 22 (2007) 1846-1851
10. Ellman G.L. Tissue sulfhydryl groups. Arch. BioChem. Biophys. 82 (1959) 70-77
11. Farombi E.O., and Ekor M. Curcumin attenuates gentamicin-induced renal oxidative damage in rats. Food Chem. Toxicol. 44 (2006) 1443-1448
12. Farombi E.O., Shrotriya S., Na H.K., Kim S.H., and Surh YJ. Curcumin attenuates dimethylnitrosamine-induced liver injury in rats through Nrf2-mediated induction of heme oxygenase-1. Food Chem. Toxicol. 46 (2008) 1279-1287
13. Fiocchi C. Inflammatory bowel disease: new insights into mechanisms of inflammation and increasingly customized approaches to diagnosis and therapy. Curr. Opin. Gastroenterol. 20 (2004) 309-310
14. Geier M.S., Butler R.N., and Howarth G.S. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics. Int. J. Food Microbiol. 115 (2007) 1-11
15. Goel A., Kunnumakkara A.B., and Aggarwal B.B. Curcumin as "Curecumin": from kitchen to clinic. Biochem. Pharmacol. 75 (2008) 787-809
16. Habig W.H., Pabst M.J., and Jakoby W.B. Glutathione-S-transferase: the first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249 (1974) 7130-7139
17. Hartz P.H. Simultaneous histologic fixation and gross demonstration of calcification. Am. J. Clin. Pathol. 17 (1947) 750-755
18. Herias M.V., Koninkx J.F., Vos J.G., Huis in't Veld J.H., and van Dijk J.E. Probiotic effects of Lactobacillus casei on DSS-induced ulcerative colitis in mice. Int. J. Food Microbiol. 103 (2005) 143-155
19. Holma R., Salmenperä P., Riutta A., Virtanen I., Korpela R., and Vapaatalo H. Acute effects of the cys-leukotriene-1 receptor antagonist, montelukast, on experimental colitis in rats. Eur. J. Pharmacol. 429 (2001) 309-318
20. Jacob A., Wu R., Zhou M., and Wang P. Mechanism of the anti-inflammatory effect of curcumin: PPAR-gamma activation. PPAR Res. 20 (2007) 89369-89374
21. Jiang H., Deng C.S., Zhang M., and Xia J. Curcumin-attenuated trinitrobenzene sulphonic acid induces chronic colitis by inhibiting expression of cyclooxygenase-2. World J. Gastroenterol. 12 (2006) 3848-3853
22. Kawada M., Arihiro A., and Mizoguchi E. Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease. World J. Gastroenterol. 13 (2007) 5581-5593
23. Korkina L., Suprun M., Petrova A., Mikhal'chik E., Luci A., and De Luca C. The protective and healing effects of a natural antioxidant formulation based on ubiquinol and Aloe vera against dextran sulfate-induced ulcerative colitis in rats. Biofactors 18 (2003) 255-264
24. Kozuch P.L., and Hanauer S.B. Treatment of inflammatory bowel disease: a review of medical therapy. World J. Gastroenterol. 14 (2008) 354-377
25. Kuhad A., and Chopra K. Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences. Eur. J. Pharmacol. 576 (2007) 34-42
26. Kuhad A., Pilkhwal S., Sharma S., Tirkey N., and Chopra K. Effect of curcumin on inflammation and oxidative stress in cisplatin-induced experimental nephrotoxicity. J. Agric. Food Chem. 55 (2007) 10150-10155
27. Kumar P., Padi S.S., Naidu P.S., and Kumar A. Possible neuroprotective mechanisms of curcumin in attenuating 3-nitropropionic acid-induced neurotoxicity. Methods Find Exp. Clin. Pharmacol. 29 (2007) 19-25
28. Lian Q., Li X., Shang Y., Yao S., Ma L., and Jin S. Protective effect of curcumin on endotoxin-induced acute lung injury in rats. J. Huazhong Univ. Sci. Technol. Med. Sci. 26 (2006) 678-681
29. Loftus E.V. Management of extraintestinal manifestations and other complications of inflammatory bowel disease. Curr. Gastroenterol. Rep. 6 (2004) 313-506
30. Maheshwari R.K., Singh A.K., Gaddipati J., and Srimal R.C. Multiple biological activities of curcumin: a short review. Life Sci. 18 (2006) 2081-2087
31. Manktelow A., and Meyer A. Lack of correlation between decreases chemotaxis and susceptibility to infection in burned rats. J. Trauma 26 (1986) 143-148
32. Martelli L., Ragazzi E., di Mario F., Martelli M., Castagliuolom I., Dal Maschio M., Palù G., Maschietto M., Scorzeto M., Vassanelli S., and Brun P. A potential role for the vanilloid receptor TRPV1 in the therapeutic effect of curcumin in dinitrobenzene sulphonic acid-induced colitis in mice. Neurogastroenterol. Motil. 19 (2007) 668-674
33. Miranda K.M., Espey M.G., and Wink D.A. A rapid, simple spectrophotometric method for simultaneous detection of Nitrate and Nitrite. Nitric Oxide 5 (2001) 62-71
34. Murugan P., and Pari L. Influence of tetrahydrocurcumin on hepatic and renal functional markers and protein levels in experimental type 2 diabetic rats. Basic Clin. Pharmacol. Toxicol. 101 (2007) 241-245
35. Mustafa A., El-Medany A., Hagar H.H., and El-Medany G. Ginkgo biloba attenuates mucosal damage in a rat model of ulcerative colitis. Pharmacol. Res. 53 (2006) 324-330
36. Osman N., Adawi D., Ahrné S., Jeppsson B., and Molin G. Probiotics and blueberry attenuate the severity of dextran sulfate sodium (DSS)-induced colitis. Digest. Dis. Sci. 53 (2008) 2464-2473
37. Reyes-Gordillo K., Segovia J., Shibayama M., Vergara P., Moreno M.G., and Muriel P. Curcumin protects against acute liver damage in the rat by inhibiting NF-kappaB, proinflammatory cytokines production and oxidative stress. Biochim. Biophys. Acta 1770 (2007) 989-996
38. Rezaie A., Parker R.D., and Abdollahi M. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause?. Digest. Dis. Sci. 52 (2007) 2015-2021
39. Rumi G., Tsubouchi R., Nishio H., Kato S., Mózsik G., and Takeuchi K. Dual role of endogenous nitric oxide in development of dextran sodium sulfate-induced colitis in rats. J. Physiol. Pharmacol. 55 (2004) 823-836
40. Sands B.E., and Kaplan G.G. The role of TNFalpha in ulcerative colitis. J. Clin. Pharmacol. 47 (2007) 930-941
41. Seril D.N., Liao J., Yang G.Y., and Yang C.S. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 24 (2003) 353-362
42. Sharma R.A., Steward W.P., and Gescher A.J. Pharmacokinetics and pharmacodynamics of curcumin. Adv. Exp. Med. Biol. 595 (2007) 453-470
43. Song W.B., Zhang Z.S., and Xiao B. Protective effect of curcumin against methotrexate-induced small intestinal damage in rats. Nan Fang Yi Ke Da Xue Xue Bao 28 (2008) 119-121
44. Thangapazham R.L., Puri A., Tele S., Blumenthal R., and Maheshwari R.K. Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells. Int. J. Oncol. 32 (2008) 119-1123
45. Tsune I., Ikejima K., Hirose M., Yoshikawa M., Enomoto N., Takei Y., and Sato N. Dietary glycine prevents chemical induced experimental colitis in the rat. Gastroenterology 125 (2003) 775-785
46. Uchiyama M., and Mihara K. Determination of malondialdelyde precursor in tissue by thiobarbituric acid test. Anal. Biochem. 86 (1978) 271-278
47. Ukil A., Maity S., Karmakar S., Datta N., Vedasiromoni J.R., and Das P.K. Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis. Br. J. Pharmacol. 139 (2003) 209-218
48. Van Crombruggen K., Van Nassauw L., Demetter P., Cuvelier C., Timmermans J.P., and Lefebvre R.A. Influence of soluble guanylate cyclase inhibition on inflammation and motility disturbances in DSS-induced colitis. Eur. J. Pharmacol. 579 (2008) 337-349
49. Venkataranganna M.V., Rafiq M., Gopumadhavan S., Peer G., and Babu U.V. Mitra SKNCB-02 (standardized curcumin preparation) protects dinitrochlorobenzene- induced colitis through down-regulation of NFkappa-B and iNOS. World J. Gastroenterol. 13 (2007) 1103-1107
50. Villegas I., Alarcón de la Lastra C., Orjales A., and La Casa C.A. New flavonoid derivative, dosmalfate, attenuates the development of dextran sulphate sodium-induced colitis in mice. Int. Immunopharmacol. 3 (2003) 1731-1741
51. Winterbourn C.C., and Brennan S.O. Characterization of the oxidation products of the reaction between reduced glutathione and hypochlorous acid. Biochem. J. 326 (1997) 87-92
52. Wolters G., Kuijpers L.P., Kacaki J., and Schuurs A.H. Enzyme-linked immunosorbent assay for hepatitis B surface antigen. J. Infect. Dis. 136 (1977) 311-317